Cost-Effectiveness of Adding Rituximab to Fludarabine and Cyclophosphamide for Treatment of Chronic Lymphocytic Leukemia in Ukraine

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s79258
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab as Initial Therapy for Chronic Lymphocytic Leukemia

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

The Role of Combined Fludarabine, Cyclophosphamide and Rituximab Chemoimmunotherapy in Chronic Lymphocytic Leukemia: Current Evidence and Controversies

Therapeutic Advances in Hematology
Hematology
2016English

Prognostic Role of CD4 T-Cell Depletion After Frontline Fludarabine, Cyclophosphamide and Rituximab in Chronic Lymphocytic Leukaemia

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Treatment-Related Acute Myeloid Leukemia in a Chronic Lymphocytic Leukemia Patient: Role of Fludarabine?

Therapeutic Advances in Hematology
Hematology
2015English

Rituximab–cyclophosphamide–dexamethasone Combination in the Management of Autoimmune Cytopenias Associated With Chronic Lymphocytic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Comparative Efficacy of Chronic Lymphocytic Leukemia Treatment With or Without Rituximab

Oncogematologiya
OncologyHematology
2019English

Fludarabine Plus Cyclophosphamide and Rituximab in Waldenstrom Macroglobulinemia

Cancer
Cancer ResearchOncology
2011English

Rituximab in Combination With High-Dose Methylprednisolone for the Treatment of Chronic Lymphocytic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Cost-Utility of Idelalisib in Combination With Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy